Connection

Pål Aukrust to Non-ST Elevated Myocardial Infarction

Back to Details
This is a "connection" page, showing publications Pål Aukrust has written about Non-ST Elevated Myocardial Infarction.
Pål Aukrust
Connection Strength
0.483
Non-ST Elevated Myocardial Infarction
  1. IL-6 Receptor Inhibition by Tocilizumab Attenuated Expression of C5a Receptor 1 and 2 in Non-ST-Elevation Myocardial Infarction. Front Immunol. 2018; 9:2035.
    View in: PubMed
    Score: 0.125
  2. Interleukin-6 receptor inhibition with tocilizumab induces a selective and substantial increase in plasma IP-10 and MIP-1ß in non-ST-elevation myocardial infarction. Int J Cardiol. 2018 Nov 15; 271:1-7.
    View in: PubMed
    Score: 0.123
  3. Serum lipoprotein(a) is not modified by interleukin-6 receptor antagonism or associated with inflammation in non-ST-elevation myocardial infarction. Int J Cardiol. 2019 Jan 01; 274:348-350.
    View in: PubMed
    Score: 0.123
  4. Effect of interleukin-6 inhibition on coronary microvascular and endothelial function in myocardial infarction. Heart. 2017 10; 103(19):1521-1527.
    View in: PubMed
    Score: 0.113
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.